发明授权
US08945833B2 Method for determining drug resistance mutations in any of the non-structural protein regions NS3 to NS5B of hepatitis C virus (HCV) for genotypes 1 to 6
有权
用于确定基因型1至6的丙型肝炎病毒(HCV)的非结构蛋白质NS3至NS5B的任何非结构蛋白质区域中的耐药突变的方法
- 专利标题: Method for determining drug resistance mutations in any of the non-structural protein regions NS3 to NS5B of hepatitis C virus (HCV) for genotypes 1 to 6
- 专利标题(中): 用于确定基因型1至6的丙型肝炎病毒(HCV)的非结构蛋白质NS3至NS5B的任何非结构蛋白质区域中的耐药突变的方法
-
申请号: US13122614申请日: 2009-10-06
-
公开(公告)号: US08945833B2公开(公告)日: 2015-02-03
- 发明人: Lieven Jozef Stuyver , Diana Koletzki , Jan Martin Berke , Ina Isabel Vandenbroucke , Leen Roger Vijgen
- 申请人: Lieven Jozef Stuyver , Diana Koletzki , Jan Martin Berke , Ina Isabel Vandenbroucke , Leen Roger Vijgen
- 优先权: EP08165949 20081006
- 国际申请: PCT/EP2009/062986 WO 20091006
- 国际公布: WO2010/040756 WO 20100415
- 主分类号: C12Q1/68
- IPC分类号: C12Q1/68 ; C12Q1/70
摘要:
The present invention relates to a method for determining drug resistance mutations in any of the non-structural protein regions NS3 to NS5B of Hepatitis C Virus (HCV) for genotypes 1 to 6, more in particular for subtype specific genotypes 1a, 1b, 2a, 2b, 3a, 4a and 4d.